AGENTS, USES AND METHODS FOR TREATMENT

• 收藏
• 分享

专利权人:

H. LUNDBECK A/S

发明人:

BIILMANN RØNN, Lars,MALIK, Ibrahim,STAVENHAGEN, Jeffrey,CHRISTENSEN, Søren,EGEBJERG, Jan,STUMMANN, Tina,GERRITSEN, Arnout,VAN DEN BRINK, Edward,PARREN, Paul,TRABJERG, Esben,RAND, Kasper Dyrberg

申请号：

SG11201912228W

公开号：

SG11201912228WA

申请日:

2018.07.18

申请国别(地区):

SG

年份:

2020

代理人:

摘要：

The present invention relates to monoclonal anti-Sortilin antibodies which have been found useful in correcting a deficient level of progranulin (PGRN). In particular, these antibodies can be used in the treatment of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) and other neurodegenerative disorders such as Alzheimers disease (AD).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/